XEN445 is primarily investigated for its potential therapeutic applications in treating various medical conditions. It is being studied for its role in modulating specific biological pathways, which could make it effective in addressing diseases related to metabolic disorders or neurological conditions. Research focuses on its ability to target and regulate key enzymes or receptors, potentially offering a novel approach to managing symptoms or progression of these diseases. Its application is currently in the preclinical or early clinical trial stages, with the aim of developing it into a viable treatment option for patients.